Bofukang vaginal suppository for aerobic vaginitis symptoms
Part of Women’s health & pregnancy clinical trials.
This trial studies whether Bofukang vaginal suppositories can improve symptoms and abnormal vaginal test results in people with aerobic vaginitis. If you meet the specific diagnosis and safety criteria, it may offer a structured treatment plan and follow-up to see how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with aerobic vaginitis based on your vaginal discharge, vaginal pH over 4.5, and a Donders score of 3 or higher
- You have no signs of other vaginal infections (like gonorrhea or herpes) and no cervical/vulvar conditions such as cervical erosion or other vulvar diseases
- You have not used antibiotic or antifungal medicines by mouth or in the vagina within the past 2 weeks
- You are not pregnant, breastfeeding, or planning pregnancy during the study
- You do not have serious medical problems like significant liver/kidney problems, weak immunity, diabetes, or serious mental illness (psychosis)
- You are not allergic to Bofukang or its ingredients, and you can reliably follow study visits and instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication called WXSH0102 for treating vaginal yeast infections (VVC). It aims to see if the drug is safe and effective for women with active symptoms.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This trial tests a vaginal ovule (a small insert) medical device to treat bacterial vaginosis and yeast infections. It aims to see if the device is safe and effective at relieving symptoms like discharge, itching, and burning.
This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.
This trial tests a single dose of an investigational drug given vaginally to healthy Chinese women. It aims to see if the drug is safe and how the body processes it.
This trial tests a vaginal gel to treat and prevent common vaginal infections like yeast infections (VVC) and bacterial vaginosis (BV). It may help if you currently have symptoms like itching, discharge, or odor.
Hear when a new Vaginitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.